Nang Kuang Pharmaceutical Co Ltd
Nang Kuang Pharmaceutical Co., Ltd. manufactures, processes, trades in, imports, and exports pharmaceuticals and medical devices in Taiwan, China, Japan, the United States, and internationally. The company offers ready to use injections, such as prefilled syringe injections and premixed IV infusions; anti-aging and preventive medicines; chemotherapy and oncology products; and non-PVC IV infusion.… Read more
Nang Kuang Pharmaceutical Co Ltd (1752) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2025: 0.072x
Based on the latest financial reports, Nang Kuang Pharmaceutical Co Ltd (1752) has a cash flow conversion efficiency ratio of 0.072x as of December 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$179.67 Million) by net assets (NT$2.49 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Nang Kuang Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2009–2025)
This chart illustrates how Nang Kuang Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Nang Kuang Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Nang Kuang Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Datalex
IR:DLE
|
-26.424x |
|
Lotte Chemical Titan Holding BHD
KLSE:5284
|
-0.072x |
|
Duksung Co Ltd
KO:004835
|
0.014x |
|
Hi-Lai Foods Co Ltd
TWO:1268
|
0.092x |
|
Noble Development Public Company Limited
BK:NOBLE
|
0.052x |
|
Eisen- und Hüttenwerke AG
F:EIS
|
-0.005x |
|
GD Express Carrier Bhd
KLSE:0078
|
0.053x |
|
Bank Nationalnobu Tbk
JK:NOBU
|
-0.108x |
Annual Cash Flow Conversion Efficiency for Nang Kuang Pharmaceutical Co Ltd (2009–2025)
The table below shows the annual cash flow conversion efficiency of Nang Kuang Pharmaceutical Co Ltd from 2009 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | NT$2.49 Billion | NT$464.08 Million | 0.186x | -3.21% |
| 2024-12-31 | NT$2.42 Billion | NT$466.43 Million | 0.193x | +33.62% |
| 2023-12-31 | NT$2.38 Billion | NT$342.61 Million | 0.144x | -5.88% |
| 2022-12-31 | NT$2.41 Billion | NT$369.19 Million | 0.153x | -38.37% |
| 2021-12-31 | NT$2.24 Billion | NT$556.63 Million | 0.248x | +262.74% |
| 2020-12-31 | NT$2.20 Billion | NT$151.01 Million | 0.068x | -61.20% |
| 2019-12-31 | NT$2.19 Billion | NT$386.19 Million | 0.177x | -0.99% |
| 2018-12-31 | NT$2.05 Billion | NT$366.12 Million | 0.178x | +18.43% |
| 2017-12-31 | NT$2.14 Billion | NT$322.71 Million | 0.151x | -21.06% |
| 2016-12-31 | NT$2.12 Billion | NT$404.99 Million | 0.191x | +9.24% |
| 2015-12-31 | NT$1.99 Billion | NT$348.23 Million | 0.175x | +11.94% |
| 2014-12-31 | NT$1.44 Billion | NT$224.83 Million | 0.156x | +167.32% |
| 2013-12-31 | NT$1.43 Billion | NT$83.18 Million | 0.058x | -66.56% |
| 2012-12-31 | NT$928.02 Million | NT$161.92 Million | 0.174x | +176.26% |
| 2011-12-31 | NT$802.34 Million | NT$50.67 Million | 0.063x | -25.17% |
| 2010-12-31 | NT$803.36 Million | NT$67.80 Million | 0.084x | -28.71% |
| 2009-12-31 | NT$816.05 Million | NT$96.60 Million | 0.118x | -- |